Empire BlueCross BlueShield – Medical Policy and Clinical Guideline Updates

Revised Medical Policies Effective 02-27-2020

(The following policies were revised to expand medical necessity indications or criteria.)

• 00011 – Gene Expression Profiling for Managing Breast Cancer Treatment
• 00103 – Intraocular Anterior Segment Aqueous Drainage Devices (without extraocular reservoir)

Revised Medical Policies Effective 04-01-2020

(The following policies were updated with CPT/HCPCS procedure code updates.)

• 00052 – Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling

00019 – Serum Markers for Liver Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease

Source: https://providernews.empireblue.com/article/medical-policy-and-clinical-guideline-updates-3